Clinical evidence further supports this mechanism, showing that patients with ulcerative colitis (UC) in remission exhibit significantly higher levels of FoxO4 expression compared to those with active disease, with a positive correlation observed between FoxO4 expression and histological healing. The gene discussed is FOXO4; the disease is ulcerative colitis.